Vanguard Capital Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Vanguard Capital Management's PRCT Position: Q3 2026 in Review
Vanguard Capital Management reduced its Procept Biorobotics (PRCT) stake by 2% in Q3 2026, selling an estimated $960K and leaving 2,412,651 shares worth $44M. The position accounts for ﹤0.01% of the portfolio, ranked #1958.
Vanguard Capital Management first reported a position in PRCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $60M in Q1 2026. 229 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Vanguard Capital Management held 2,412,651 shares of Procept Biorobotics worth $44M as of Q3 2026.
- Vanguard Capital Management sold 48,151 Procept Biorobotics shares in Q3 2026, an estimated $960K.
- Procept Biorobotics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1958 holding.
- Vanguard Capital Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Procept Biorobotics position peaked at $60M in Q1 2026.
- 229 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.